(function(doc, html, url) { var widget = doc.createElement("div"); widget.innerHTML = html; var script = doc.currentScript; // e = a.currentScript; if (!script) { var scripts = doc.scripts; for (var i = 0; i < scripts.length; ++i) { script = scripts[i]; if (script.src && script.src.indexOf(url) != -1) break; } } script.parentElement.replaceChild(widget, script); }(document, '

Could brain-gut photobiomodulation have therapeutic potential for Alzheimer’s disease?

What is it about?

Recent innovative non-pharmacological interventions and neurostimulation devices have shown potential for application in the treatment of Alzheimer’s disease. These include photobiomodulation therapy. This randomized control trial assesses a brain-gut photobiomodulation therapy for Alzheimer’s disease patients.

Why is it important?

This is the first randomized controlled trial in Alzheimer's disease evaluating the first medical device that targets the brain-gut axis. The brain-gut photobiomodulation therapy proved to be safe. The majority of the patients were highly compliant. Despite its reduced statistical power due in part to the premature study termination related to the COVID-19 pandemic, this study also highlights encouraging efficacy trends on certain outcomes.

Read more on Kudos…
The following have contributed to this page:
Guillaume Blivet
' ,"url"));